20 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250520570730/en/ZEVTERA-ceftobiprole-an-Advanced-Generation-Cephalosporin-Antibiotic-Now-Commercially-Available-in-the-U.S.-to-Treat-Three-Types-of-Bacterial-Infections
16 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/16/3062270/0/en/Basilea-reports-presentation-of-new-data-for-fosmanogepix-isavuconazole-Cresemba-and-ceftobiprole-Zevtera-at-ESCMID-Global-2025.html
28 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/28/3016062/0/en/Strong-sales-growth-for-Cresemba-and-Zevtera-trigger-further-milestone-payments-to-Basilea.html
16 Dec 2024
// BUSINESSWIRE
03 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/03/2874833/0/en/Basilea-reports-presentation-of-new-data-for-ceftobiprole-Zevtera-at-ESCMID-Global-2024.html
17 Oct 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/10/17/2761159/0/en/Basilea-reports-new-data-for-ceftobiprole-Zevtera-presented-at-US-IDWeek-Congress-2023.html